Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) closed the day trading at $130.88 down -3.23% from the previous closing price of $135.25. In other words, the price has decreased by -$3.23 from its previous closing price. On the day, 1.8 million shares were traded. JAZZ stock price reached its highest trading level at $134.88 during the session, while it also had its lowest trading level at $128.0315.
Ratios:
For a better understanding of JAZZ, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.66 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.85. For the most recent quarter (mrq), Quick Ratio is recorded 3.99 and its Current Ratio is at 4.46. In the meantime, Its Debt-to-Equity ratio is 1.51 whereas as Long-Term Debt/Eq ratio is at 1.50.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on March 07, 2025, Upgraded its rating to Buy and sets its target price to $179 from $145 previously.
Wells Fargo Upgraded its Equal Weight to Overweight on February 13, 2025, whereas the target price for the stock was revised from $130 to $170.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 10 ’25 when Iannone Robert sold 2,403 shares for $138.41 per share. The transaction valued at 332,605 led to the insider holds 79,621 shares of the business.
Carr Patricia sold 1,140 shares of JAZZ for $157,103 on Mar 10 ’25. The SVP, Chief Accounting Officer now owns 7,012 shares after completing the transaction at $137.81 per share. On Mar 10 ’25, another insider, Iannone Robert, who serves as the Officer of the company, bought 1,767 shares for $145.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JAZZ now has a Market Capitalization of 8214068224 and an Enterprise Value of 11121762304. As of this moment, Jazz’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.05, and their Forward P/E ratio for the next fiscal year is 5.67. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.72. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.95 while its Price-to-Book (P/B) ratio in mrq is 1.94. Its current Enterprise Value per Revenue stands at 2.733 whereas that against EBITDA is 7.309.
Stock Price History:
The Beta on a monthly basis for JAZZ is 0.38, which has changed by 0.1223135 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, JAZZ has reached a high of $148.06, while it has fallen to a 52-week low of $99.06. The 50-Day Moving Average of the stock is -0.85%, while the 200-Day Moving Average is calculated to be 10.63%.
Shares Statistics:
Over the past 3-months, JAZZ traded about 837.39K shares per day on average, while over the past 10 days, JAZZ traded about 1288260 shares per day. A total of 60.63M shares are outstanding, with a floating share count of 57.97M. Insiders hold about 4.54% of the company’s shares, while institutions hold 97.55% stake in the company. Shares short for JAZZ as of 1741910400 were 4522312 with a Short Ratio of 5.40, compared to 1739491200 on 4531222. Therefore, it implies a Short% of Shares Outstanding of 4522312 and a Short% of Float of 9.91.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
